Memantine Therapy for Multiple Sclerosis (Memantine-MS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00638833
Recruitment Status : Terminated (Unexpected side-effects: reversible and mild to moderate neurological impairment)
First Posted : March 19, 2008
Last Update Posted : June 8, 2012
H. Lundbeck A/S
Information provided by (Responsible Party):
Clinica Universidad de Navarra, Universidad de Navarra